What are the causes of thrombocytopenia and febrile neutropenia?

Causes of Thrombocytopenia and Febrile Neutropenia

Febrile Neutropenia: Definition and Primary Causes

Febrile neutropenia is defined as fever >38.5°C for >1 hour with absolute neutrophil count (ANC) <0.5 × 10⁹/L, and is most commonly caused by chemotherapy-induced bone marrow suppression in cancer patients. 1

Primary Underlying Causes of Febrile Neutropenia

Chemotherapy-induced myelosuppression:

• Standard-dose chemotherapy for malignancies causes febrile neutropenia in up to 10-57% of patients 1
• Acute myeloid leukemia (AML) induction/consolidation chemotherapy causes febrile neutropenia in 35-48% of patients 1
• Autologous and allogeneic stem cell transplantation regularly causes febrile neutropenia 1

Hematologic malignancies:

• Refractory hematologic malignancies cause marrow failure from the disease itself and from multiple prior cytotoxic therapies 1
• Heavily pretreated patients with fludarabine-refractory chronic lymphocytic leukemia (CLL) experience serious infectious complications requiring hospitalization in nearly 90% of cases 1

Solid tumors with anatomic complications:

• Tumors that outgrow their blood supply become necrotic, forming a nidus for infection 1
• Endobronchial tumors cause recurrent postobstructive pneumonias 1
• Abdominal tumors obstruct genitourinary or hepatobiliary tracts, predisposing to pyelonephritis and cholangitis 1

Infectious Pathogens Causing Fever in Neutropenic Patients

Early bacterial pathogens (initial infections):

• Gram-positive organisms: Coagulase-negative staphylococci, S. aureus, viridans group streptococci, and enterococci 1
• Gram-negative organisms: E. coli, Klebsiella, Enterobacter species, and Pseudomonas aeruginosa 1
• Approximately 50-60% of febrile neutropenic patients have an established or occult infection 1
• 10-20% of patients with neutrophil counts <100/mcL develop bloodstream infections 1

Later pathogens (subsequent infections):

• Antibiotic-resistant bacteria, yeasts, fungi, and viruses become common causes after initial treatment 1
• Candida species occur later in neutropenia, particularly with gastrointestinal mucositis 1
• Aspergillus species and filamentous fungi cause life-threatening sinopulmonary infections after >2 weeks of neutropenia 1
• Viral pathogens include HSV, RSV, parainfluenza, and influenza A and B 1

Primary infection sites:

• Alimentary tract (mouth, pharynx, esophagus, large and small bowel, rectum), sinuses, lungs, and skin 1

Risk Factors Amplifying Infection Risk

Severity and duration of neutropenia:

• Risk of severe infection is greatest when ANC <100/mcL 1
• Duration of neutropenia >7 days significantly increases infection risk 1
• Rate of neutrophil count decline correlates with bone marrow reserve and infection severity 1

Disruption of mucosal barriers:

• Chemotherapy and radiation therapy impair mucosal immunity at multiple levels 1
• Loss of epithelial barrier allows local flora invasion 1
• Gastrointestinal mucositis predisposes to bloodstream infections by viridans group streptococci, gram-negative rods, and Candida species 1
• Neutropenia plus epithelial barrier loss may cause typhlitis (neutropenic enterocolitis) 1

---

Causes of Thrombocytopenia in Cancer Patients

Thrombocytopenia in febrile neutropenic patients is primarily caused by chemotherapy-induced bone marrow suppression, with additional contributions from infection-related consumption, splenic sequestration, and drug effects. 1, 2

Primary Mechanisms of Thrombocytopenia

Decreased platelet production:

• Chemotherapy-induced bone marrow suppression is the most common cause in cancer patients 1
• Hematologic malignancies directly infiltrating bone marrow reduce platelet production 2
• Risk for severe thrombocytopenia increases when hematopoietic growth factors are given immediately before or simultaneously with chemotherapy 1

Increased platelet destruction:

• Immune thrombocytopenia (ITP) in patients without systemic illness 2
• Drug-induced thrombocytopenia from chemotherapy agents 2
• Infection-related consumption in septicemia and severe infections 3

Splenic sequestration:

• Hepatic disease causing portal hypertension and splenomegaly 2
• Up to one-third of total platelet mass can be sequestered in enlarged spleens 2

Dilutional thrombocytopenia:

• Massive fluid resuscitation or blood product transfusion 2

Infectious Causes of Thrombocytopenia

Dengue fever:

• Most common infectious cause of febrile thrombocytopenia in endemic areas 3
• Bleeding manifestations occur in 42.7% of patients with dengue-associated thrombocytopenia 3

Malaria:

• Second most common infectious cause after dengue 3
• Accounts for 6.55% of deaths in febrile thrombocytopenia 3

Septicemia:

• Accounts for 85.24% of deaths in febrile thrombocytopenia 3
• Mortality not directly associated with degree of thrombocytopenia but with multiorgan dysfunction 3

Other infections:

• Leptospirosis, viral infections (HSV, VZV), and opportunistic pathogens including Pneumocystis jirovecii 1

Clinical Significance of Platelet Count Thresholds

Bleeding risk stratification:

• Platelet count >50 × 10³/μL: Generally asymptomatic 2
• Platelet count 20-50 × 10³/μL: Mild skin manifestations (petechiae, purpura, ecchymosis) 2
• Platelet count ≤50 × 10³/μL: Petechiae/purpura more commonly observed 4, 3
• Platelet count <20 × 10³/μL: Spontaneous bleeding noted 3
• Platelet count <10 × 10³/μL: High risk of serious bleeding 2

Procedural considerations:

• Platelet counts <50 × 10³/μL require activity restrictions to avoid trauma-associated bleeding 2
• Adequate platelet counts must be ensured before invasive procedures, potentially requiring platelet transfusion 2

---

Critical Clinical Pitfalls

Delayed antibiotic administration:

• Earlier administration of antibiotics is associated with fewer complications in febrile neutropenia 4
• Empirical antibiotic therapy must be initiated urgently within 2 hours of presentation 1
• Latency of first antibiotic dose is an independent factor associated with serious complications 4

Underestimating infection risk:

• Signs and symptoms of infection are often absent or muted in neutropenic patients, but fever remains an early indicator 1
• Even minor skin lesions in neutropenic patients can represent serious infections 5
• Deaths from infections identified at onset of fever are uncommon; most infection-related deaths result from subsequent infections during prolonged neutropenia 1

Thrombocytopenia-specific risks:

• Conditions exist where both bleeding and thrombosis occur: antiphospholipid syndrome, heparin-induced thrombocytopenia, and thrombotic microangiopathies 2
• Mortality in febrile thrombocytopenia correlates with concomitant organ involvement, not platelet count alone 3

G-CSF contraindications:

• G-CSF is contraindicated during chest radiotherapy due to increased complications and death 1
• Risk for severe thrombocytopenia when hematopoietic growth factors are given immediately before or with chemotherapy 1